Phosphoramidate derivatives of 2′,3′-didehydro-2′,3′-dideoxyadenosine [d4A] have markedly improved anti-HIV potency and selectivity

This publication has 16 references indexed in Scilit:

• Equal inhibition of the replication of human immunodeficiency virus in human T-cell culture by ddA BIS(SATE)phosphotriester and 3′-azido-2′,3′-dideoxythymidine
  Biochemical Pharmacology, 1994
• Phosphate derivatives of d4T as inhibitors of HIV
  Bioorganic & Medicinal Chemistry Letters, 1993
• Intracellular delivery of bioactive AZT nucleotides by aryl phosphate derivatives of AZT
  Journal of Medicinal Chemistry, 1993
• An Efficient and General Synthesis of 5′-Esters of 2′,3′-Didehydro-2′,3′-dideoxynucleosides: A Facile Opening of 2′,3′-Orthoacetates of Ribonucleosides Followed by Reductive Elimination of the Halogenoacetates
  Synthesis, 1993
• Attempts to introduce chemotherapeutic nucleotides into cells: studies on the anti-HIV agent FDT
  Bioorganic & Medicinal Chemistry Letters, 1991
• Synthesis and biological properties of novel phosphotriesters: a new approach to the introduction of biologically active nucleotides into cells
  Journal of Medicinal Chemistry, 1990
• Synthesis and biological evaluation of some phosphate triester derivatives of the anti-cancer drug AraC
  Nucleic Acids Research, 1989
• Synthesis and biological evaluation of some phosphate triester derivatives of the anti-viral drug AraA
  Nucleic Acids Research, 1989
• Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivity
  Biochemical Pharmacology, 1987
• Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro
  Biochemical and Biophysical Research Communications, 1987